The commonality of protein interaction networks determined in neurodegenerative disorders (NDDs)
暂无分享,去创建一个
Susumu Goto | Minoru Kanehisa | Kunihiro Ueda | Vachiranee Limviphuvadh | Seigo Tanaka | M. Kanehisa | S. Goto | K. Ueda | Seigo Tanaka | Vachiranee Limviphuvadh
[1] G. Stephanopoulos,et al. A compendium of gene expression in normal human tissues. , 2001, Physiological genomics.
[2] C. Dobson,et al. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases , 2002, Nature.
[3] D. Bredesen,et al. Misfolded proteins, endoplasmic reticulum stress and neurodegeneration. , 2004, Current opinion in cell biology.
[4] F. Hartl,et al. Roles of molecular chaperones in protein misfolding diseases. , 2004, Seminars in cell & developmental biology.
[5] Andrew F Hill,et al. Delineating common molecular mechanisms in Alzheimer's and prion diseases. , 2006, Trends in biochemical sciences.
[6] Pier Andrea Serra,et al. Glucocorticoid receptor–nitric oxide crosstalk and vulnerability to experimental parkinsonism: pivotal role for glia–neuron interactions , 2005, Brain Research Reviews.
[7] P Choi,et al. alpha-Synuclein shares physical and functional homology with 14-3-3 proteins. , 1999, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[8] F. Giorgini,et al. Connecting the dots in Huntington's disease with protein interaction networks , 2005, Genome Biology.
[9] Robert D. Finn,et al. Pfam: clans, web tools and services , 2005, Nucleic Acids Res..
[10] B. Margolis,et al. The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein , 1996, Molecular and cellular biology.
[11] Christopher A. Ross,et al. Atrophin-1, the DRPLA Gene Product, Interacts with Two Families of WW Domain-Containing Proteins , 1998, Molecular and Cellular Neuroscience.
[12] Zheng Jing,et al. Focal adhesions regulate Abeta signaling and cell death in Alzheimer's disease. , 2007, Biochimica et biophysica acta.
[13] Chi V Dang,et al. Multifaceted roles of glycolytic enzymes. , 2005, Trends in biochemical sciences.
[14] Peter M Mathisen,et al. Gene discovery and validation for neurodegenerative diseases. , 2003, Drug discovery today.
[15] Hanno Steen,et al. Development of human protein reference database as an initial platform for approaching systems biology in humans. , 2003, Genome research.
[16] C. MacKintosh,et al. Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes. , 2004, The Biochemical journal.
[17] Peter M. Haverty,et al. HugeIndex: a database with visualization tools for high-density oligonucleotide array data from normal human tissues , 2002, Nucleic Acids Res..
[18] D. Morrison,et al. Unlocking the code of 14-3-3 , 2004, Journal of Cell Science.
[19] S. Lipton,et al. Molecular pathways to neurodegeneration , 2004, Nature Medicine.
[20] A Caricasole,et al. Two Sides of the Same Coin: Wnt Signaling in Neurodegeneration and Neuro-Oncology , 2005, Bioscience reports.
[21] Sean R. Eddy,et al. Profile hidden Markov models , 1998, Bioinform..
[22] C. Ross,et al. Protein aggregation and neurodegenerative disease , 2004, Nature Medicine.
[23] D. Chuang,et al. Glyceraldehyde-3-phosphate dehydrogenase, apoptosis, and neurodegenerative diseases. , 2005, Annual review of pharmacology and toxicology.
[24] Jennifer L Mazzola,et al. Alteration of intracellular structure and function of glyceraldehyde-3-phosphate dehydrogenase: a common phenotype of neurodegenerative disorders? , 2002, Neurotoxicology.
[25] L. Petrucelli,et al. α-Synuclein Shares Physical and Functional Homology with 14-3-3 Proteins , 1999, The Journal of Neuroscience.
[26] H. Lehrach,et al. A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease. , 2004, Molecular cell.
[27] D. Butterfield,et al. REVIEW: Pin1 in Alzheimer's disease , 2006, Journal of neurochemistry.
[28] Takashi Kudo,et al. The Unfolded Protein Response Is Involved in the Pathology of Alzheimer's Disease , 2002, Annals of the New York Academy of Sciences.
[29] Marius Sudol,et al. WW and SH3 domains, two different scaffolds to recognize proline‐rich ligands , 2002, FEBS letters.
[30] I. Vincent,et al. The cell cycle and human neurodegenerative disease. , 2003, Progress in cell cycle research.
[31] Asma Nusrat,et al. Association of BAP31 with CD11b/CD18 , 2004, Journal of Biological Chemistry.
[32] P. Lantos,et al. Overlap between neurodegenerative disorders , 2005, Neuropathology : official journal of the Japanese Society of Neuropathology.
[33] Nobutaka Hirokawa,et al. Molecular motors in neuronal development, intracellular transport and diseases , 2004, Current Opinion in Neurobiology.
[34] Kiyoko F. Aoki-Kinoshita,et al. From genomics to chemical genomics: new developments in KEGG , 2005, Nucleic Acids Res..
[35] Carl W. Cotman,et al. Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis , 2003, Science.